OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

10472	Companies
220549	Keywords
149878	Articles
116636	Press releases

Home
Companies
OXURION

BRIEF

published on 09/08/2025 at 18:05, 8 months 21 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Atlas Special Opportunities Financial Risks Oxurion
PRESS RELEASE

published on 09/08/2025 at 18:00, 8 months 21 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Change Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 09/01/2025 at 18:05, 8 months 28 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Atlas Special Opportunities Oxurion Participation Thresholds
PRESS RELEASE

published on 09/01/2025 at 18:00, 8 months 28 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in voting securities holdings

Oxurion NV Belgian Legislation Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
BRIEF

published on 08/07/2025 at 18:05, 9 months 22 days ago

Oxurion receives transparency notifications from UBS Group AG

Investors Actions Transparency UBS Group AG Oxurion
PRESS RELEASE

published on 08/07/2025 at 18:00, 9 months 22 days ago

Oxurion Receives Transparency Notifications from UBS Group AG
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on therapeutic innovation and clinical research technologies

Clinical Research Biopharmaceutical UBS Group AG Oxurion NV Transparency Notifications
BRIEF

published on 08/06/2025 at 18:05, 9 months 23 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 08/06/2025 at 18:00, 9 months 23 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC as per Belgian Transparency legislation. Company combines therapeutic innovation with technology for new treatments

Clinical Research Shareholding Changes Oxurion NV Therapeutic Innovation Transparency Notifications
BRIEF

published on 08/04/2025 at 18:05, 9 months 25 days ago

Oxurion Secures EUR 30M for Diversification into Digital Assets

Funding Investment Cryptocurrencies Biopharmaceuticals Oxurion
PRESS RELEASE

published on 08/04/2025 at 18:00, 9 months 25 days ago

Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Oxurion NV receives €30 million financing offer from Atlas Special Opportunities for investment in digital assets. Company remains confident in closing the transaction by August 2025

Investment Digital Assets Oxurion NV Financing Offer August 2025

Accesswire

Published on 05/30/2026 at 01:30, 48 minutes ago

Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 1 hour 47 minutes ago

Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 3 hours 18 minutes ago

The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 05/29/2026 at 23:00, 3 hours 18 minutes ago

IBC Advanced Alloys Reports Improved Financial Results for the Quarter Ended March 2026
Published on 05/29/2026 at 22:20, 3 hours 58 minutes ago

Pathfinder Ventures Inc Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933

View all ACCESSWIRE

EQS Group

Published on 05/29/2026 at 21:42, 4 hours 35 minutes ago

EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 4 hours 48 minutes ago

Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 6 hours 18 minutes ago

Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 6 hours 31 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 6 hours 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/29/2026 at 22:00, 4 hours 18 minutes ago

Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 8 hours 18 minutes ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 8 hours 25 minutes ago

Share buyback mandate
Published on 05/29/2026 at 12:00, 14 hours 18 minutes ago

Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 15 hours 48 minutes ago

bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market

View all LES ECHOS COMFI WIRE